CClinicalTrials.gg
Status unknownNCT05542186Updated Sep 15, 2022

Immediate Effects of Kinesio Taping on Pain and Postural Stability in Persons With Discogenic Low Back Pain.

An interventional study of Kinesiotaping in Low Back Pain, sponsored by Foundation University Islamabad. Status unknown at 1 site in Pakistan. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-09-15.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
20 Years to 65 Years
Sex
All
01

Study summary

Discogenic LBP is the leading cause of disability worldwide. Eventhough other types of Chronic LBP are more common, 63% of all patients reporting to tertiary care hospital with LBP are discogenic in nature. However, immediate effects of kinesio-taping on pain and postural stability in discogenic low back pain has not been well documented in existing literature. This study is focused on immediate effects of kinesiotaping on pain and postural stability in persons with discogenic low back pain.

02

Conditions studied

  • Low Back Pain
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Foundation University Islamabad is the lead sponsor of 238 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants in an age range of 20-65 years will be considered for this study.
  • Participants with disc bulge, herniation or prolapse indicate by MRI.
  • Positive straight leg raise (SLR) Positive centralization and peripheralization phenomenon.
  • Participants with MRI findings conclusive of disc pathology will be included.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Kinesiotaping

    Procedure: Kinesiotaping

Interventions

  • ProcedureKinesiotaping

    Biomechanical correction for discogenic low back pain using kinesiotaping

06

What researchers measure

Primary outcomes

  1. Pain Pressure Threshold

    Pain Pressure Threshold will be measured using algometer before and after the treatment session. Higher score signifies positive outcome.

    Time frame: 1 day

  2. Back Pain

    Pain will be measured using numeric pain rating scale before and after the treatment session. Higher score signifies negative outcome.

    Time frame: 1 day

  3. Postural Stability

    Postural Stability will be measured using Biodex Balance System before and after the treatment session

    Time frame: 1 day

07

Study locations

1 site
  • Foundation University
    Islamabad, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05542186
Lead sponsor
Foundation University Islamabad
Responsible party
Sponsor
First posted
Sep 15, 2022
Start date
Sep 2022 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Apr 2023 (estimated)
Last update
Sep 15, 2022

Study contacts

Bisma Mazhar, MS
principal investigator · FUI
Muhammad Osama, PhD*
study chair · FUI

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion